Faron Pharmaceuticals Oy (GB:FARN) has released an update.
Faron Pharmaceuticals Oy has reported a significant change in share ownership following a recent Share Offering, with Timo Syrjälä and Acme Investments SPF Sarl disclosing a combined voting rights interest of over 15%. This shift comes after an acquisition or disposal of voting rights and financial instruments, resulting in Syrjälä directly holding a 5.28% stake and Acme Investments indirectly holding 10.03%, as detailed in a notification submitted on June 20, 2024.
For further insights into GB:FARN stock, check out TipRanks’ Stock Analysis page.
